MedTrace Logo

Humoral and Cellular Response in Shift Workers

NCT01528280 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2018-01-11

No results posted yet for this study

Summary

The purpose of this study is to access whether shift workers (morning, afternoon or night) vaccinated against hepatitis A would have some humoral and cellular response impairment.

Conditions

  • Other Condition That May be a Focus of Clinical Attention

Interventions

BIOLOGICAL

Vaccination against hepatitis A

Vaccination against hepatitis A (2 doses) into the deltoid muscle of the nondominant arm twice, i.e., at 0 and 6 months.

OTHER

No Intervention

No Intervention

Sponsors & Collaborators

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

    collaborator OTHER_GOV

  • Federal University of São Paulo

    lead OTHER

Principal Investigators

  • Marco Tulio Mello, Associate Professor · Federal University of São Paulo

  • Francieli Silva Ruiz, PhD · Federal University of São Paulo

  • Andrea Maculano, PhD · Federal University of São Paulo

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-09-30
Completion
2016-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01528280 on ClinicalTrials.gov